Healthpeak Properties (NYSE:DOC) Updates FY24 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY24 earnings guidance on Monday. The company provided earnings per share guidance of $1.80-$1.82 for the period, compared to the consensus earnings per share estimate of $1.80.

Healthpeak Properties Stock Up 0.0 %

NYSE:DOC traded up $0.01 during mid-day trading on Monday, hitting $20.87. 5,160,296 shares of the company’s stock traded hands, compared to its average volume of 5,742,458. The company has a fifty day moving average of $22.26 and a 200 day moving average of $21.08. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. Healthpeak Properties has a twelve month low of $16.01 and a twelve month high of $23.26. The company has a market capitalization of $14.60 billion, a P/E ratio of 44.38, a P/E/G ratio of 2.32 and a beta of 1.13.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The company had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The firm’s revenue for the quarter was up 25.9% on a year-over-year basis. During the same quarter last year, the business earned $0.45 earnings per share. On average, analysts forecast that Healthpeak Properties will post 1.8 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.75%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s payout ratio is 255.32%.

Analyst Ratings Changes

A number of equities analysts recently commented on DOC shares. Evercore ISI lifted their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, September 16th. Scotiabank boosted their target price on shares of Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a report on Monday, September 9th. Wells Fargo & Company restated an “equal weight” rating and set a $23.00 price target (up previously from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Citigroup upped their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Robert W. Baird lifted their target price on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.86.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.